Header Logo

Connection

Roger Harrison to Neoplasms

This is a "connection" page, showing publications Roger Harrison has written about Neoplasms.
Connection Strength

0.984
  1. Annexin A5 as a targeting agent for cancer treatment. Cancer Lett. 2022 10 28; 547:215857.
    View in: PubMed
    Score: 0.450
  2. Antitumor Synergism and Enhanced Survival with a Tumor Vasculature-Targeted Enzyme Prodrug System, Rapamycin, and Cyclophosphamide. Mol Cancer Ther. 2017 09; 16(9):1855-1865.
    View in: PubMed
    Score: 0.313
  3. Vascular targeted single-walled carbon nanotubes for near-infrared light therapy of cancer. Nanotechnology. 2011 Nov 11; 22(45):455101.
    View in: PubMed
    Score: 0.212
  4. A soluble tissue factor-annexin V chimeric protein has both procoagulant and anticoagulant properties. Blood. 2006 Feb 01; 107(3):980-6.
    View in: PubMed
    Score: 0.009
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.